73 results on '"Edelman, A. J."'
Search Results
2. Differential Gene Expression in Erlotinib-Treated Fibroblasts
3. Daily Diary Study of Hope, Stigma, and Functioning in Lung Cancer Patients
4. The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy*
5. Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non–Small Cell Lung Cancer: NRG Oncology RTOG 0839
6. Highlights in the Treatment of Lung Cancer: What’s New? Not Much
7. Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
8. Pharmacogenomic agreement between two cancer cell line data sets
9. Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non–Small-Cell Lung Cancer
10. Impact of defined clinical population and missing data on temporal trends in HIV viral load estimation within a health care system*
11. Visualization of Latent Blood Stains Using Visible Reflectance Hyperspectral Imaging and Chemometrics
12. Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
13. Natural history of hypercoagulability in patients undergoing coronary revascularization and effect of preoperative myocardial infarction
14. Response to comments on the dynamics of network dynamics
15. The dynamics of animal social networks: analytical, conceptual, and theoretical advances
16. Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer
17. Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
18. Chemotherapy Outcomes by Histologic Subtypes of Non–Small-Cell Lung Cancer: Analysis of the Southwest Oncology Group Database for Antimicrotubule-Platinum Therapy
19. Infrared Imaging of the Crime Scene: Possibilities and Pitfalls
20. Opportunities and Challenges in the Era of Molecularly Targeted Agents and Radiation Therapy
21. Anaortic, off-pump coronary artery surgery: should it be the standard-of-care?
22. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
23. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
24. Treatment Rationale Study Design for the MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non–Small-Cell Lung Cancer
25. Multicenter Trial of EC145 in Advanced, Folate-Receptor Positive Adenocarcinoma of the Lung
26. Maintenance Therapy and Advanced Non–Small-Cell Lung Cancer: A Skeptic’s View
27. Epothilones in Development for Non–Small-Cell Lung Cancer: Novel Anti-Tubulin Agents With the Potential to Overcome Taxane Resistance
28. CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304
29. Systematic identification of genomic markers of drug sensitivity in cancer cells
30. Anaortic off-pump coronary artery bypass grafting: The criterion standard for minimization of neurologic injury
31. Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B 150304
32. Bortezomib for Patients with Advanced-Stage Bronchioloalveolar Carcinoma: A California Cancer Consortium Phase II Study (NCI 7003)
33. Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib
34. Sex-specific effects of size and condition on timing of natal dispersal in kangaroo rats
35. Population-Based Estimates of Survival Benefit Associated with Combined Modality Therapy in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer
36. Multicenter Phase II Trial of Motexafin Gadolinium and Pemetrexed for Second-Line Treatment in Patients with Non-small Cell Lung Cancer
37. EML4/ALK and Ras Inhibitors
38. A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer
39. Outcomes Associated with Brain Metastases in a Three-Arm Phase III Trial of Gemcitabine-Containing Regimens Versus Paclitaxel Plus Carboplatin for Advanced Non-small Cell Lung Cancer
40. Targeted Radiopharmaceutical Therapy for Advanced Lung Cancer: Phase I Trial of Rhenium Re188 P2045, a Somatostatin Analog
41. Phase 1-2a Multicenter Dose-Ranging Study of Canfosfamide in Combination with Carboplatin and Paclitaxel as First-Line Therapy for Patients with Advanced Non-small Cell Lung Cancer
42. Pemetrexed plus Cetuximab in Patients with Recurrent Non-small Cell Lung Cancer (NSCLC): A Phase I/II Study from the Hoosier Oncology Group
43. Cooperative Group Research Efforts in Thoracic Malignancies 2009 A Review From the 10th Annual International Lung Cancer Congress
44. Impact of Preoperative Chemotherapy on Pulmonary Function Tests in Resectable Early-Stage Non-small Cell Lung Cancer*
45. When is prophylaxis for hereditary angioedema necessary?
46. Pemetrexed-Induced Typhlitis in Non-small Cell Lung Cancer
47. Phase II Randomized Study of Dose-Dense Docetaxel and Cisplatin Every 2 Weeks With Pegfilgrastim and Darbepoetin Alfa With and Without the Chemoprotector BNP7787 in Patients With Advanced Non-small Cell Lung Cancer (CALGB 30303)
48. Neoadjuvant Chemotherapy with Gemcitabine-Containing Regimens in Patients with Early-Stage Non-small Cell Lung Cancer
49. Lung Cancer in HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy
50. Influence of female-biased sexual size dimorphism on dominance of female Townsendʼs chipmunks
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.